In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations

Elena De Vecchi, Lucia Nicola, Monica Larosa, Lorenzo Drago

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background. Haemophilus influenzae is one of the main aetiological agents of community-acquired respiratory tract infections. The primary aim of this study was to evaluate the antibacterial activity of telithromycin against H. influenzae clinical isolates showing different pattern of resistance in comparison with azithromycin and clarithromycin at 1/4 ×, 1/2 ×, 1 ×, 2 ×, 4 × minimum inhibitory concentration (MIC) and to peak concentrations in epithelial lining fluid (ELF). The secondary aim was to determine the influence of CO2enriched atmosphere on bacterial susceptibility. Results. Telithromycin showed high activity against H. influenzae, including strains susceptible to β-lactams (n = 200), β-lactamase producer (n = 50) and β-lactamase negative ampicillin resistant (BLNAR) (n = 10), with MIC from ≤0.03 to 4 mg/L, and MIC 50/MIC90of 1/2 mg/L with susceptibility rate of 100%, and minimum bactericidal concentrations (MBC) from 2 to 4-fold higher than the MIC. Azithromycin was the most active tested macrolide (range: 0.25 - 4 mg/L; MIC50/MIC90: 1/2 mg/L), comparable to telithromycin, while clarithromycin showed the highest MICs and MBCs (range: 0.25 - 8 mg/L; MIC 50/MIC90: 2/8 mg/L). In time-kill studies, telithromycin showed a bactericidal activity at the higher concentrations (4 - 2 × MIC and ELF) against all the strains, being complete after 12 - 24 hours from drug exposition. At MIC concentrations, at ambient air, bactericidal activity of telithromycin and azithromycin was quite similar at 12 hours, and better than that of clarithromycin. Besides, telithromycin and clarithromycin at ELF concentrations were bactericidal after 12 hours of incubation for most strains, while 24 hours were needed to azithromycin to be bactericidal. Incubation in CO2significantly influenced the MICs and MBCs, and only slightly the in vitro killing curves. Conclusion. Telithromycin showed an in-vitro potency against H. influenzae comparable to azithromycin, with an in-vitro killing rate more rapid and superior to clarithromycin at 2X-MIC against β-lactamase producers and BLNAR strains, and to azithromycin at ELF concentrations against β-lactamase negative strains. Against all strains, MICs and MBCs were lower in the absence of CO2for the tested antibiotics, showing an adverse effect of incubation in a CO2environment. The in-vitro potency together with the tissue concentrations of the antimicrobial, should be considered in predicting efficacy.

Original languageEnglish
Article number23
JournalBMC Microbiology
Volume8
DOIs
Publication statusPublished - 2008

Fingerprint

Haemophilus influenzae
Microbial Sensitivity Tests
Azithromycin
Clarithromycin
Inhibitory Concentration 50
Community-Acquired Infections
Lactams
In Vitro Techniques
telithromycin
Macrolides
Ampicillin
Atmosphere
Respiratory Tract Infections
Air
Anti-Bacterial Agents
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations. / De Vecchi, Elena; Nicola, Lucia; Larosa, Monica; Drago, Lorenzo.

In: BMC Microbiology, Vol. 8, 23, 2008.

Research output: Contribution to journalArticle

@article{024b8dc32bf74d1d9082bb7c3894de3f,
title = "In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations",
abstract = "Background. Haemophilus influenzae is one of the main aetiological agents of community-acquired respiratory tract infections. The primary aim of this study was to evaluate the antibacterial activity of telithromycin against H. influenzae clinical isolates showing different pattern of resistance in comparison with azithromycin and clarithromycin at 1/4 ×, 1/2 ×, 1 ×, 2 ×, 4 × minimum inhibitory concentration (MIC) and to peak concentrations in epithelial lining fluid (ELF). The secondary aim was to determine the influence of CO2enriched atmosphere on bacterial susceptibility. Results. Telithromycin showed high activity against H. influenzae, including strains susceptible to β-lactams (n = 200), β-lactamase producer (n = 50) and β-lactamase negative ampicillin resistant (BLNAR) (n = 10), with MIC from ≤0.03 to 4 mg/L, and MIC 50/MIC90of 1/2 mg/L with susceptibility rate of 100{\%}, and minimum bactericidal concentrations (MBC) from 2 to 4-fold higher than the MIC. Azithromycin was the most active tested macrolide (range: 0.25 - 4 mg/L; MIC50/MIC90: 1/2 mg/L), comparable to telithromycin, while clarithromycin showed the highest MICs and MBCs (range: 0.25 - 8 mg/L; MIC 50/MIC90: 2/8 mg/L). In time-kill studies, telithromycin showed a bactericidal activity at the higher concentrations (4 - 2 × MIC and ELF) against all the strains, being complete after 12 - 24 hours from drug exposition. At MIC concentrations, at ambient air, bactericidal activity of telithromycin and azithromycin was quite similar at 12 hours, and better than that of clarithromycin. Besides, telithromycin and clarithromycin at ELF concentrations were bactericidal after 12 hours of incubation for most strains, while 24 hours were needed to azithromycin to be bactericidal. Incubation in CO2significantly influenced the MICs and MBCs, and only slightly the in vitro killing curves. Conclusion. Telithromycin showed an in-vitro potency against H. influenzae comparable to azithromycin, with an in-vitro killing rate more rapid and superior to clarithromycin at 2X-MIC against β-lactamase producers and BLNAR strains, and to azithromycin at ELF concentrations against β-lactamase negative strains. Against all strains, MICs and MBCs were lower in the absence of CO2for the tested antibiotics, showing an adverse effect of incubation in a CO2environment. The in-vitro potency together with the tissue concentrations of the antimicrobial, should be considered in predicting efficacy.",
author = "{De Vecchi}, Elena and Lucia Nicola and Monica Larosa and Lorenzo Drago",
year = "2008",
doi = "10.1186/1471-2180-8-23",
language = "English",
volume = "8",
journal = "BMC Microbiology",
issn = "1471-2180",
publisher = "BioMed Central",

}

TY - JOUR

T1 - In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations

AU - De Vecchi, Elena

AU - Nicola, Lucia

AU - Larosa, Monica

AU - Drago, Lorenzo

PY - 2008

Y1 - 2008

N2 - Background. Haemophilus influenzae is one of the main aetiological agents of community-acquired respiratory tract infections. The primary aim of this study was to evaluate the antibacterial activity of telithromycin against H. influenzae clinical isolates showing different pattern of resistance in comparison with azithromycin and clarithromycin at 1/4 ×, 1/2 ×, 1 ×, 2 ×, 4 × minimum inhibitory concentration (MIC) and to peak concentrations in epithelial lining fluid (ELF). The secondary aim was to determine the influence of CO2enriched atmosphere on bacterial susceptibility. Results. Telithromycin showed high activity against H. influenzae, including strains susceptible to β-lactams (n = 200), β-lactamase producer (n = 50) and β-lactamase negative ampicillin resistant (BLNAR) (n = 10), with MIC from ≤0.03 to 4 mg/L, and MIC 50/MIC90of 1/2 mg/L with susceptibility rate of 100%, and minimum bactericidal concentrations (MBC) from 2 to 4-fold higher than the MIC. Azithromycin was the most active tested macrolide (range: 0.25 - 4 mg/L; MIC50/MIC90: 1/2 mg/L), comparable to telithromycin, while clarithromycin showed the highest MICs and MBCs (range: 0.25 - 8 mg/L; MIC 50/MIC90: 2/8 mg/L). In time-kill studies, telithromycin showed a bactericidal activity at the higher concentrations (4 - 2 × MIC and ELF) against all the strains, being complete after 12 - 24 hours from drug exposition. At MIC concentrations, at ambient air, bactericidal activity of telithromycin and azithromycin was quite similar at 12 hours, and better than that of clarithromycin. Besides, telithromycin and clarithromycin at ELF concentrations were bactericidal after 12 hours of incubation for most strains, while 24 hours were needed to azithromycin to be bactericidal. Incubation in CO2significantly influenced the MICs and MBCs, and only slightly the in vitro killing curves. Conclusion. Telithromycin showed an in-vitro potency against H. influenzae comparable to azithromycin, with an in-vitro killing rate more rapid and superior to clarithromycin at 2X-MIC against β-lactamase producers and BLNAR strains, and to azithromycin at ELF concentrations against β-lactamase negative strains. Against all strains, MICs and MBCs were lower in the absence of CO2for the tested antibiotics, showing an adverse effect of incubation in a CO2environment. The in-vitro potency together with the tissue concentrations of the antimicrobial, should be considered in predicting efficacy.

AB - Background. Haemophilus influenzae is one of the main aetiological agents of community-acquired respiratory tract infections. The primary aim of this study was to evaluate the antibacterial activity of telithromycin against H. influenzae clinical isolates showing different pattern of resistance in comparison with azithromycin and clarithromycin at 1/4 ×, 1/2 ×, 1 ×, 2 ×, 4 × minimum inhibitory concentration (MIC) and to peak concentrations in epithelial lining fluid (ELF). The secondary aim was to determine the influence of CO2enriched atmosphere on bacterial susceptibility. Results. Telithromycin showed high activity against H. influenzae, including strains susceptible to β-lactams (n = 200), β-lactamase producer (n = 50) and β-lactamase negative ampicillin resistant (BLNAR) (n = 10), with MIC from ≤0.03 to 4 mg/L, and MIC 50/MIC90of 1/2 mg/L with susceptibility rate of 100%, and minimum bactericidal concentrations (MBC) from 2 to 4-fold higher than the MIC. Azithromycin was the most active tested macrolide (range: 0.25 - 4 mg/L; MIC50/MIC90: 1/2 mg/L), comparable to telithromycin, while clarithromycin showed the highest MICs and MBCs (range: 0.25 - 8 mg/L; MIC 50/MIC90: 2/8 mg/L). In time-kill studies, telithromycin showed a bactericidal activity at the higher concentrations (4 - 2 × MIC and ELF) against all the strains, being complete after 12 - 24 hours from drug exposition. At MIC concentrations, at ambient air, bactericidal activity of telithromycin and azithromycin was quite similar at 12 hours, and better than that of clarithromycin. Besides, telithromycin and clarithromycin at ELF concentrations were bactericidal after 12 hours of incubation for most strains, while 24 hours were needed to azithromycin to be bactericidal. Incubation in CO2significantly influenced the MICs and MBCs, and only slightly the in vitro killing curves. Conclusion. Telithromycin showed an in-vitro potency against H. influenzae comparable to azithromycin, with an in-vitro killing rate more rapid and superior to clarithromycin at 2X-MIC against β-lactamase producers and BLNAR strains, and to azithromycin at ELF concentrations against β-lactamase negative strains. Against all strains, MICs and MBCs were lower in the absence of CO2for the tested antibiotics, showing an adverse effect of incubation in a CO2environment. The in-vitro potency together with the tissue concentrations of the antimicrobial, should be considered in predicting efficacy.

UR - http://www.scopus.com/inward/record.url?scp=41149118912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149118912&partnerID=8YFLogxK

U2 - 10.1186/1471-2180-8-23

DO - 10.1186/1471-2180-8-23

M3 - Article

C2 - 18230154

AN - SCOPUS:41149118912

VL - 8

JO - BMC Microbiology

JF - BMC Microbiology

SN - 1471-2180

M1 - 23

ER -